ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.

85,013 comparisons

Most participants first33,758 with no events in either group come last1,761 to 1,780 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
Treatment - Participation in Nurse Family Partnership vs Control: deaths from any cause5 of 3,319

2 of 1,647

0.0 points

-0.3 to 0.2

4,966NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Drug-specific Alert vs Usual Care: Percentage of Patients With AKI Progression From Stage 2 to Stage 3231 of 2,470

256 of 2,478

-1.0 points

-2.6 to 0.7

4,948NCT02771977

Drug-Targeted Alerts for Acute Kidney Injury

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants Experiencing Neonatal Morbidity328 of 3,295

144 of 1,647

1.2 points

-0.5 to 2.9

4,942NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants Whose Child Had an Emergency Department Visit2,306 of 3,295

1,192 of 1,637

-2.8 points

-5.5 to -0.1

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With a Family Planning Visit (1 Year)2,378 of 3,295

1,188 of 1,637

-0.4 points

-3.0 to 2.3

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants Whose Child Experienced a Major Injury or Concern for Abuse or Neglect901 of 3,295

438 of 1,637

0.6 points

-2.1 to 3.2

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With a Mental Health Diagnosis or Outpatient Treatment1,048 of 3,295

543 of 1,637

-1.4 points

-4.2 to 1.4

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With an Inter-birth Interval of < 15 Months148 of 3,295

85 of 1,637

-0.7 points

-2.1 to 0.5

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With Recommended Number of Well-child Visits1,150 of 3,295

537 of 1,637

2.1 points

-0.7 to 4.9

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With SNAP or TANF Benefit Churn382 of 3,295

174 of 1,637

1.0 points

-0.9 to 2.8

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With a Dental Visit1,096 of 3,295

509 of 1,637

2.2 points

-0.6 to 4.9

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants Experiencing Violence or Homicide55 of 3,295

27 of 1,637

0.0 points

-0.8 to 0.7

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants Whose Child Experienced Concern for Abuse or Neglect137 of 3,295

66 of 1,637

0.1 points

-1.1 to 1.3

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With a Mental Health Treatment Follow up292 of 3,295

142 of 1,637

0.2 points

-1.5 to 1.8

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants Experiencing Neonatal Abstinence Disorder (NAS) or Maternal Drug/Substance Abuse708 of 3,295

367 of 1,637

-0.9 points

-3.4 to 1.5

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With an Outpatient Mental Health Visit165 of 3,295

76 of 1,637

0.4 points

-1.0 to 1.6

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants Who Received a Postpartum Intrauterine Device Insertion (1 Year)476 of 3,295

227 of 1,637

0.6 points

-1.5 to 2.6

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With Lead Screening2,093 of 3,295

1,030 of 1,637

0.6 points

-2.2 to 3.5

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants Experiencing Cesarean Delivery1,015 of 3,295

530 of 1,637

-1.6 points

-4.4 to 1.2

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Treatment - Participation in Nurse Family Partnership Nurse-Family Partnership vs Control: Number of Participants With an Inter-birth Interval of < 21 Months363 of 3,295

199 of 1,637

-1.1 points

-3.1 to 0.7

4,932NCT03360539

Nurse-Family Partnership Impact Evaluation in South Carolina

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=89

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03360539-deaths",
        "title": "Treatment - Participation in Nurse Family Partnership vs Control: deaths from any cause",
        "summary": "5 of 3319 against 2 of 1647; risk difference 0.0 points, 95% interval -0.3 to 0.2; NCT03360539, Nurse-Family Partnership Impact Evaluation in South Carolina",
        "record": "/library/comparisons/NCT03360539-deaths",
        "nct_id": "NCT03360539",
        "kind": "deaths",
        "participants": 4966,
        "risk_difference": {
          "value": 0.0002921487715939926,
          "lower": -0.0030246191058526965,
          "upper": 0.0024918203488700935
        },
        "group_1": "5 of 3,319",
        "group_2": "2 of 1,647",
        "difference": "0.0 points",
        "interval": "-0.3 to 0.2",
        "trial_title": "Nurse-Family Partnership Impact Evaluation in South Carolina"
      },
      {
        "id": "NCT02771977-e0aa922f",
        "title": "Drug-specific Alert vs Usual Care: Percentage of Patients With AKI Progression From Stage 2 to Stage 3",
        "summary": "231 of 2470 against 256 of 2478; risk difference -1.0 points, 95% interval -2.6 to 0.7; NCT02771977, Drug-Targeted Alerts for Acute Kidney Injury",
        "record": "/library/comparisons/NCT02771977-e0aa922f",
        "nct_id": "NCT02771977",
        "kind": "outcome",
        "participants": 4948,
        "risk_difference": {
          "value": -0.009786853051795066,
          "lower": -0.026424054348754306,
          "upper": 0.006837234456300877
        },
        "group_1": "231 of 2,470",
        "group_2": "256 of 2,478",
        "difference": "-1.0 points",
        "interval": "-2.6 to 0.7",
        "trial_title": "Drug-Targeted Alerts for Acute Kidney Injury"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=90",
  "request_id": "Ft7O72AXF092OhuP"
}
trial-comparisons-2026-03-23-0.1.0Next page

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Open193,990 genes2026-11-11

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?